Total Three Awards: Grand Prize of King Sejong Voluntary Service of Sharing, Award by the Minister of National Defense, and Award of Beautiful Citizen of Korea
Various Social Contribution Activities such as Scholarship Business, Medicine Aid, and Sponsorship for “Hanall-Life”
Hanall Biopharma (CEO Kim Seong-uk and CEO Park Seung-guk) has received the “Grand Prize of King Sejong Voluntary Service of Sharing” at the award ceremony of “2014 King Sejong Voluntary Service Award of Sharing” held at the National Assembly Library of Yeoeuido on 8th. Along with the “Grand Prize of King Sejong Voluntary Service of Sharing,” Hanall has received the “Award by the Minister of National Defense” and the “Award of Beautiful Citizen of Korea” to take three awards at the same time.
Fifth in this year, the “Grand Prize of King Sejong Voluntary Award of Sharing” is granted by the UN Volunteers Korea to the individuals or the groups that has greatly contributed to the development of country and local community through volunteer services and sharing, and the former Prime Minister Lee Su-seong is in charge of the award.
Hanall Biopharma has established and sponsored the scholarship foundation and the social welfare organization “Hanall-Life,” the social welfare firm for senior care, and from 2010, Hanall has been holding the campaigns of organ donation with the Korea Network for Organ Sharing. Moreover, as Hanall bring sharing to the medically vulnerable and neglected through various social contribution activities such as medicine aid and medical voluntary services, food services and visiting services for senior citizens in solitude, and connective services for volunteer service groups, the Company was highly recognized.
One of the staffs of Hanall Biopharma has said, “We are glad to be recognized for our continuous effort to support and bring interest in regions and people requiring medical volunteer services. Taking this opportunity, we will grant more sharing to those in difficulties, and we will put more effort to help them.”
NextHanall Biopharma, Sponsoring Medicines worth 82 million KRW to Community Chest of Korea
PrevHanall is Entering into the 60 Billion KRW Market with Peptic Ulcer Drug “Wibis Tab”